Pushing the limits of targeted therapy in chronic myeloid leukaemia

被引：244

作者：

O'Hare, Thomas ^{[1
]}

Zabriskie, Matthew S. ^{[1
]}

Eiring, Anna M. ^{[1
]}

Deininger, Michael W. ^{[1
]}

机构：

[1] Univ Utah, Div Hematol & Hematol Malignancies, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

来源：

NATURE REVIEWS CANCER | 2012年 / 12卷 / 08期

关键词：

CHRONIC MYELOGENOUS LEUKEMIA; KINASE DOMAIN MUTATIONS; DIAGNOSED CHRONIC-PHASE; BCR-ABL1; LYMPHOBLASTIC-LEUKEMIA; COMPLETE MOLECULAR REMISSION; PATIENTS RECEIVING IMATINIB; CHROMOSOME-POSITIVE CELLS; BCR-ABL INHIBITORS; STEM-CELLS; TYROSINE KINASE;

D O I：

10.1038/nrc3317

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tyrosine kinase inhibitor (TKI) therapy targeting the BCR-ABL1 kinase is effective against chronic myeloid leukaemia (CML), but is not curative for most patients. Minimal residual disease (MRD) is thought to reside in TKI-insensitive leukaemia stem cells (LSCs) that are not fully addicted to BCR-ABL1. Recent conceptual advances in both CML biology and therapeutic intervention have increased the potential for the elimination of CML cells, including LSCs, through simultaneous inhibition of BCR-ABL1 and other newly identified, crucial targets.

引用

页码：513 / 526

页数：14

共 50 条

[21] Chronic myeloid leukaemia
Apperley, Jane F.
LANCET, 2015, 385 (9976): : 1447 - 1459
[22] CHRONIC MYELOID LEUKAEMIA
不详
LANCET, 1949, 257 (SEP17): : 533 - 533
[23] CHRONIC MYELOID LEUKAEMIA
Cooney, Julian
INTERNAL MEDICINE JOURNAL, 2013, 43 : 10 - 10
[24] Fibroblast-mediated resistance to a novel targeted therapy is driven by myeloid cell leukaemia 1 in acute myeloid leukaemia
Miari, Katerina
Wheadon, Helen
Guzman, Monica
Barry, Simon
Williams, Mark
BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 472 - 473
[25] Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy
Mason, Clinton C.
Fiol, Carme R.
Baker, Monika J.
Nadal-Melsio, Elisabet
Yebra-Fernandez, Eva
Bicalho, Luciana
Chowdhury, Avirup
Albert, Michael
Reid, Alistair G.
Claudiani, Simone
Apperley, Jane F.
Khorashad, Jamshid S.
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 137 - 145
[26] Targeted therapy in acute myeloid leukaemia: current status and future directions
Stapnes, Camilla
Gjertsen, Bjorn Tore
Reikvam, Hakon
Bruserud, Oystein
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 433 - 455
[27] CHRONIC MYELOID LEUKAEMIA .1. SOME OBSERVATIONS ON CHRONIC MYELOID LEUKAEMIA
GALTON, DAG
BRITISH JOURNAL OF RADIOLOGY, 1953, 26 (306): : 285 - 290
[28] Can lessons learned from chronic myeloid leukaemia on targeted therapy and precision oncology be applied to other cancers
Gale, Robert Peter
LEUKEMIA RESEARCH, 2018, 73 : S1 - S1
[29] Human neutrophil elastase is not a target for therapy in chronic myeloid leukaemia
E K Allan
T L Holyoake
H G Jørgensen
Leukemia, 2006, 20 : 2054 - 2055
[30] Economics influences therapy decisions in chronic myeloid leukaemia: should it?
Jiang, Qian
Larson, Richard A.
Gale, Robert Peter
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (12) : 3693 - 3698

← 1 2 3 4 5 →